141 related articles for article (PubMed ID: 8814696)
1. The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?
Denham JW; Denham E; Dear KB; Hudson GV
Eur J Cancer; 1996 Mar; 32A(3):480-90. PubMed ID: 8814696
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
[TBL] [Abstract][Full Text] [Related]
3. TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma.
Chang S; Shi X; Xu Z; Liu Q
J BUON; 2015; 20(3):812-9. PubMed ID: 26214635
[TBL] [Abstract][Full Text] [Related]
4. Assessment of prognostic factors in follicular lymphoma patients.
Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y
Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204
[TBL] [Abstract][Full Text] [Related]
5. The follicular non-Hodgkin's lymphomas--I. The possibility of cure.
Denham JW; Denham E; Dear KB; Hudson GV
Eur J Cancer; 1996 Mar; 32A(3):470-9. PubMed ID: 8814695
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification.
Musshoff K; Schmidt-Vollmer H
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Aug; 83(4):323-41. PubMed ID: 125960
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.
Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E
Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
9. Long-term results with radiotherapy for Stage I-II follicular lymphomas.
Wilder RB; Jones D; Tucker SL; Fuller LM; Ha CS; McLaughlin P; Hess MA; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1219-27. PubMed ID: 11728680
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
11. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Decaudin D; Lepage E; Brousse N; Brice P; Harousseau JL; Belhadj K; Tilly H; Michaux L; Chèze S; Coiffier B; Solal-Céligny P
J Clin Oncol; 1999 Aug; 17(8):2499-505. PubMed ID: 10561315
[TBL] [Abstract][Full Text] [Related]
12. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas.
Rosenberg SA
Cancer Treat Rep; 1977 Sep; 61(6):1023-7. PubMed ID: 902260
[TBL] [Abstract][Full Text] [Related]
13. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
[TBL] [Abstract][Full Text] [Related]
15. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
17. [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
Sýkorová A; Belada D; Smolej L; Pytlík R; Benesová K; Vásová I; Papajík T; Sálek D; Procházka V; Matuska M; Brejcha M; Kubácková K; Kabícková E; Móciková H; Campr V; Trnený M;
Klin Onkol; 2010; 23(3):146-54. PubMed ID: 20608324
[TBL] [Abstract][Full Text] [Related]
18. [Lymphomas].
Lohri A
Praxis (Bern 1994); 2016 Jan; 105(1):47-52. PubMed ID: 26732717
[TBL] [Abstract][Full Text] [Related]
19. Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases.
Liu MT; Hsieh CY; Wang AY; Pi CP; Chang TH; Huang CC; Huang CY
Ann Saudi Med; 2005; 25(4):288-93. PubMed ID: 16212120
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
